Taking Science to Impact
Geneva Health Forum 2022: Call for Contributions
Within the overall thematic “Covid-19 Pandemic and Environmental Emergency : Reinventing Global Health in times of Global Changes!” the GHF is launching a call for contributions for the next edition of its conference taking place from 3rd to 5th May 2022.
You can submit a proposal until 15 December 2021.
More information
Missed Opportunities in Responding to Violence
Violence against women and girls is a social problem with serious long-term health, social and economic consequences. It is reaching epidemic proportions: 1 in 3 women will experience violence in their lifetime. The MISSOP project conducts two case studies in Brazil and Albania, examining the scale and causes of missed opportunities to respond to violence against women and girls in primary care and emergency departments.
Read more about the project
Antimicrobial Resistance: The Silent Pandemic
For Antimicrobial Awareness Week, Esther Künzli, Ad Interim Head of the Travel Clinic and Infectious Disease Specialist, joined us to speak about the silent killer that is currently being overshadowed by COVID-19: antimicrobial resistance (AMR).
Read the full interview
MalariaX: Defeating Malaria from the Genes to the Globe
How can we eradicate malaria? Explore cutting-edge science and technology, and examine policies needed to control and eliminate malaria. The self-paced course with lecturers from Harvard, WHO and Swiss TPH is now available for free, online and worldwide!
Enroll today!News
All News
30.11.2021
People from Low-Income Households Severely Affected by Pandemic
The COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) has been investigating the health-related and societal effects of the COVID-19 pandemic for over... More...
30.11.2021
Promising Drug Combination Treatment Against Parasitic Worm Infections
In a Phase III clinical trial, researchers at Swiss TPH have successfully gathered encouraging data to demonstrate higher efficacy of co-administration of ivermectin-albendazole in... More...
16.11.2021
Clinical Trials Completed for a New Drug to Treat Parasitic Worm Infections in Infants
The Pediatric Praziquantel Consortium completed its pivotal clinical Phase III trial of arpraziquantel – a potential new treatment option for the estimated 50 million... More...